Exact Mass: 500.2053082
Exact Mass Matches: 500.2053082
Found 500 metabolites which its exact mass value is equals to given mass value 500.2053082
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fluticasone propionate
C25H31F3O5S (500.18441920000004)
Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone propionate binds to the glucocorticoid receptor. Unbound corticosteroids cross the membranes of cells such as mast cells and eosinophils, binding with high affinity to glucocorticoid receptors (GR). The results include alteration of transcription and protein synthesis, a decreased release of leukocytic acid hydrolases, reduction in fibroblast proliferation, prevention of macrophage accumulation at inflamed sites, reduction of collagen deposition, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability and subsequent edema, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. In the management of asthma, the glucocorticoid receptor complexes down-regulates proinflammatory mediators such as interleukin-(IL)-1, 3, and 5, and up-regulates anti-inflammatory mediators such as IκB (inhibits NF-κB). Corticosteroids are the most effective anti-inflammatory therapy for allergic diseases. They are believed to inhibit T helper cell type 2 (TH2 T-cell) activation through increased immunoregulatory T cell (CD4+CD25+) suppression (PMID: 15316506). Fluticasone propionate is marketed under the brand name Flixotide and Flixonase by Allen & Hanburys, and Flovent and Flonase by GlaxoSmithKline. Fluticasone propionate is only found in individuals that have used or taken this drug. Hanburys and Flovent and Flonase by GlaxoSmithKline.; Fluticasone propionate is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. It is marketed with the brand name Flixotide and Flixonase by Allen & Fluticasone is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Austin
Austin is a mycotoxin produced by the food storage mould (Aspergillus ustus). These are sesquiterpenes containing a lactone ring. Mycotoxin production by the food storage mould (Aspergillus ustus).
Isoaustin
Isoaustin is a mycotoxin from of Penicillium diversu
Artonol C
Artonol C is found in breadfruit. Artonol C is a constituent of the bark of Artocarpus communis (breadfruit) Constituent of the bark of Artocarpus communis (breadfruit). Artonol C is found in breadfruit and fruits.
Tritoqualine
C26H32N2O8 (500.21585519999996)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists Tritoqualine is an H1-antihistamine. C471 - Enzyme Inhibitor
D-Phenylalanyl-N-[(3s)-6-Carbamimidamido-1-Chloro-2-Oxohexan-3-Yl]-L-Phenylalaninamide
Phenylalanyl-phenylalanyl-arginine chloromethyl ketone
Galactoarabinan
L-Tyrosine, N-(2-(methoxycarbonyl)phenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-
Rolapitant
Artonol C
2-((Z)-hepta-5-en-1,3-diynyl)tetrahydrofuran-2-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside|panaxfurayne B
Orbiculin D
A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by acetoxy group at position 1 and furoyloxy groups at positions 6 and 9 (the 1beta,6alpha,9alpha stereoisomer). Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production.
(3S)-3,7-anhydro-6,7-dehydroericanone 4-beta-D-glucopyranoside
(1R,4S,5R,6R,7R,8R)-3-Oxo-8-<5-(5-acetoxytiglyloxy)-tiglyloxy>-guaia-10(14),11(13)-dien-6,12-olide|(1R,4S,5R,6R,7R,8R)-3-Oxo-8-[5-(5-acetoxytiglyloxy)-tiglyloxy]-guaia-10(14),11(13)-dien-6,12-olide
O-Rutinoside-3-(3-Hydroxypropyl)phthalide|Pedirutinoside
Dodoviscin A
dodoviscin A is a natural product found in Dodonaea viscosa with data available.
cipatrijugin G|methyl rel-[(4R,4aS,6R,7aR,8S,11aS,12aR)-4-(furan-3-yl)dodecahydro-6-hydroxy-4a,7a,9,9-tetramethyl-13-methylidene-2,7,10-trioxo-4H-6,12a-methanopyrano[4,3-b][1]benzoxocin-8-yl]acetate
(1R,2S,4S,5S,6R,7R,9S,10S)-1,2,9,15-tetraacetoxy-4,6-dihydroxy-8-oxodihydro-beta-agarofuran
Dodovisone B
Fluticasone propionate
C25H31F3O5S (500.18441920000004)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Austin
CONFIDENCE Penicillium nucicola
Tritoqualine
C26H32N2O8 (500.21585519999996)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C471 - Enzyme Inhibitor
Fluticasone
C25H31F3O5S (500.18441920000004)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents CONFIDENCE standard compound; INTERNAL_ID 2831 D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ala Phe Thr Tyr
C25H32N4O7 (500.22708819999997)
Ala Phe Tyr Thr
C25H32N4O7 (500.22708819999997)
Ala His His His
C21H28N10O5 (500.22440380000006)
Ala Thr Phe Tyr
C25H32N4O7 (500.22708819999997)
Ala Thr Tyr Phe
C25H32N4O7 (500.22708819999997)
Ala Tyr Phe Thr
C25H32N4O7 (500.22708819999997)
Ala Tyr Thr Phe
C25H32N4O7 (500.22708819999997)
Cys Cys Ile Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Cys Leu Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Cys Tyr Ile
C21H32N4O6S2 (500.17631719999997)
Cys Cys Tyr Leu
C21H32N4O6S2 (500.17631719999997)
Cys Glu His Ile
Cys Glu His Leu
Cys Glu Ile His
Cys Glu Leu His
Cys Phe Met Thr
C21H32N4O6S2 (500.17631719999997)
Cys Phe Thr Met
C21H32N4O6S2 (500.17631719999997)
Cys His Glu Ile
Cys His Glu Leu
Cys His Ile Glu
Cys His Lys Asn
Cys His Leu Glu
Cys His Asn Lys
Cys His Asn Gln
Cys His Gln Asn
Cys Ile Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Ile Glu His
Cys Ile His Glu
Cys Ile Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Cys Lys His Asn
Cys Lys Asn His
Cys Leu Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Leu Glu His
Cys Leu His Glu
Cys Leu Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Cys Met Phe Thr
C21H32N4O6S2 (500.17631719999997)
Cys Met Thr Phe
C21H32N4O6S2 (500.17631719999997)
Cys Asn His Lys
Cys Asn His Gln
Cys Asn Lys His
Cys Asn Gln His
Cys Gln His Asn
Cys Gln Asn His
Cys Thr Phe Met
C21H32N4O6S2 (500.17631719999997)
Cys Thr Met Phe
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Cys Ile
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Cys Leu
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Ile Cys
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Leu Cys
C21H32N4O6S2 (500.17631719999997)
Asp Glu His Thr
C19H28N6O10 (500.18668279999997)
Asp Glu Thr His
C19H28N6O10 (500.18668279999997)
Asp Phe Gly Tyr
Asp Phe Tyr Gly
Asp Gly Phe Tyr
Asp Gly Tyr Phe
Asp His Glu Thr
C19H28N6O10 (500.18668279999997)
Asp His Met Val
Asp His Thr Glu
C19H28N6O10 (500.18668279999997)
Asp His Val Met
Asp Met His Val
Asp Met Val His
Asp Asn Pro Arg
C19H32N8O8 (500.23429919999995)
Asp Asn Arg Pro
C19H32N8O8 (500.23429919999995)
Asp Pro Asn Arg
C19H32N8O8 (500.23429919999995)
Asp Pro Arg Asn
C19H32N8O8 (500.23429919999995)
Asp Arg Asn Pro
C19H32N8O8 (500.23429919999995)
Asp Arg Pro Asn
C19H32N8O8 (500.23429919999995)
Asp Thr Glu His
C19H28N6O10 (500.18668279999997)
Asp Thr His Glu
C19H28N6O10 (500.18668279999997)
Asp Val His Met
Asp Val Met His
Asp Tyr Phe Gly
Asp Tyr Gly Phe
Glu Cys His Ile
Glu Cys His Leu
Glu Cys Ile His
Glu Cys Leu His
Glu Asp His Thr
C19H28N6O10 (500.18668279999997)
Glu Asp Thr His
C19H28N6O10 (500.18668279999997)
Glu Glu His Ser
C19H28N6O10 (500.18668279999997)
Glu Glu Ser His
C19H28N6O10 (500.18668279999997)
Glu His Cys Ile
Glu His Cys Leu
Glu His Asp Thr
C19H28N6O10 (500.18668279999997)
Glu His Glu Ser
C19H28N6O10 (500.18668279999997)
Glu His Ile Cys
Glu His Leu Cys
Glu His Ser Glu
C19H28N6O10 (500.18668279999997)
Glu His Thr Asp
C19H28N6O10 (500.18668279999997)
Glu Ile Cys His
Glu Ile His Cys
Glu Leu Cys His
Glu Leu His Cys
Glu Pro Gln Gln
C20H32N6O9 (500.22306619999995)
Glu Gln Pro Gln
C20H32N6O9 (500.22306619999995)
Glu Gln Gln Pro
C20H32N6O9 (500.22306619999995)
Glu Ser Glu His
C19H28N6O10 (500.18668279999997)
Glu Ser His Glu
C19H28N6O10 (500.18668279999997)
Glu Thr Asp His
C19H28N6O10 (500.18668279999997)
Glu Thr His Asp
C19H28N6O10 (500.18668279999997)
Phe Ala Thr Tyr
C25H32N4O7 (500.22708819999997)
Phe Ala Tyr Thr
C25H32N4O7 (500.22708819999997)
Phe Cys Met Thr
C21H32N4O6S2 (500.17631719999997)
Phe Cys Thr Met
C21H32N4O6S2 (500.17631719999997)
Phe Asp Gly Tyr
Phe Asp Tyr Gly
Phe Phe Gly Met
Phe Phe Met Gly
Phe Phe Ser Thr
C25H32N4O7 (500.22708819999997)
Phe Phe Thr Ser
C25H32N4O7 (500.22708819999997)
Phe Gly Asp Tyr
Phe Gly Phe Met
Phe Gly Met Phe
Phe Gly Tyr Asp
Phe Met Cys Thr
C21H32N4O6S2 (500.17631719999997)
Phe Met Phe Gly
Phe Met Gly Phe
Phe Met Thr Cys
C21H32N4O6S2 (500.17631719999997)
Phe Ser Phe Thr
C25H32N4O7 (500.22708819999997)
Phe Ser Thr Phe
C25H32N4O7 (500.22708819999997)
Phe Thr Ala Tyr
C25H32N4O7 (500.22708819999997)
Phe Thr Cys Met
C21H32N4O6S2 (500.17631719999997)
Phe Thr Phe Ser
C25H32N4O7 (500.22708819999997)
Phe Thr Met Cys
C21H32N4O6S2 (500.17631719999997)
Phe Thr Ser Phe
C25H32N4O7 (500.22708819999997)
Phe Thr Tyr Ala
C25H32N4O7 (500.22708819999997)
Phe Tyr Ala Thr
C25H32N4O7 (500.22708819999997)
Phe Tyr Asp Gly
Phe Tyr Gly Asp
Phe Tyr Thr Ala
C25H32N4O7 (500.22708819999997)
Gly Asp Phe Tyr
Gly Asp Tyr Phe
Gly Phe Asp Tyr
Gly Phe Phe Met
Gly Phe Met Phe
Gly Phe Tyr Asp
Gly Met Phe Phe
Gly Met Met Tyr
C21H32N4O6S2 (500.17631719999997)
Gly Met Tyr Met
C21H32N4O6S2 (500.17631719999997)
Gly Val Tyr Tyr
C25H32N4O7 (500.22708819999997)
Gly Tyr Asp Phe
Gly Tyr Phe Asp
Gly Tyr Val Tyr
C25H32N4O7 (500.22708819999997)
Gly Tyr Tyr Val
C25H32N4O7 (500.22708819999997)
His Ala His His
C21H28N10O5 (500.22440380000006)
His Cys Glu Ile
His Cys Glu Leu
His Cys Ile Glu
His Cys Lys Asn
His Cys Leu Glu
His Cys Asn Lys
His Cys Asn Gln
His Cys Gln Asn
His Asp Glu Thr
C19H28N6O10 (500.18668279999997)
His Asp Met Val
His Asp Thr Glu
C19H28N6O10 (500.18668279999997)
His Asp Val Met
His Glu Cys Ile
His Glu Cys Leu
His Glu Asp Thr
C19H28N6O10 (500.18668279999997)
His Glu Glu Ser
C19H28N6O10 (500.18668279999997)
His Glu Ile Cys
His Glu Leu Cys
His Glu Ser Glu
C19H28N6O10 (500.18668279999997)
His Glu Thr Asp
C19H28N6O10 (500.18668279999997)
His His Ala His
C21H28N10O5 (500.22440380000006)
His His His Ala
C21H28N10O5 (500.22440380000006)
His Ile Cys Glu
His Ile Glu Cys
His Lys Cys Asn
His Lys Asn Cys
His Leu Cys Glu
His Leu Glu Cys
His Met Asp Val
His Met Val Asp
His Asn Cys Lys
His Asn Cys Gln
His Asn Lys Cys
His Asn Gln Cys
His Gln Cys Asn
His Gln Asn Cys
His Ser Glu Glu
C19H28N6O10 (500.18668279999997)
His Thr Asp Glu
C19H28N6O10 (500.18668279999997)
His Thr Glu Asp
C19H28N6O10 (500.18668279999997)
His Val Asp Met
His Val Met Asp
Ile Cys Glu His
Ile Cys His Glu
Ile Glu Cys His
Ile Glu His Cys
Ile His Cys Glu
Ile His Glu Cys
Lys Cys His Asn
Lys Cys Asn His
Lys His Cys Asn
Lys His Asn Cys
Lys Asn Cys His
Lys Asn His Cys
Leu Cys Glu His
Leu Cys His Glu
Leu Glu Cys His
Leu Glu His Cys
Leu His Cys Glu
Leu His Glu Cys
Met Asp His Val
Met Asp Val His
Met Phe Phe Gly
Met Phe Gly Phe
Met Gly Phe Phe
Met His Asp Val
Met His Val Asp
Met Ser Thr Tyr
Met Ser Tyr Thr
Met Thr Ser Tyr
Met Thr Tyr Ser
Met Val Asp His
Met Val His Asp
Met Tyr Ser Thr
Met Tyr Thr Ser
Asn Cys His Lys
Asn Cys His Gln
Asn Cys Lys His
Asn Cys Gln His
Asn Asp Pro Arg
C19H32N8O8 (500.23429919999995)
Asn Asp Arg Pro
C19H32N8O8 (500.23429919999995)
Asn His Cys Lys
Asn His Cys Gln
Asn His Lys Cys
Asn His Gln Cys
Asn Lys Cys His
Asn Lys His Cys
Asn Pro Asp Arg
C19H32N8O8 (500.23429919999995)
Asn Pro Arg Asp
C19H32N8O8 (500.23429919999995)
Asn Gln Cys His
Asn Gln His Cys
Asn Arg Asp Pro
C19H32N8O8 (500.23429919999995)
Asn Arg Pro Asp
C19H32N8O8 (500.23429919999995)
Pro Asp Asn Arg
C19H32N8O8 (500.23429919999995)
Pro Asp Arg Asn
C19H32N8O8 (500.23429919999995)
Pro Glu Gln Gln
C20H32N6O9 (500.22306619999995)
Pro Asn Asp Arg
C19H32N8O8 (500.23429919999995)
Pro Asn Arg Asp
C19H32N8O8 (500.23429919999995)
Pro Gln Glu Gln
C20H32N6O9 (500.22306619999995)
Pro Gln Gln Glu
C20H32N6O9 (500.22306619999995)
Pro Arg Asp Asn
C19H32N8O8 (500.23429919999995)
Pro Arg Asn Asp
C19H32N8O8 (500.23429919999995)
Gln Cys His Asn
Gln Cys Asn His
Gln Glu Pro Gln
C20H32N6O9 (500.22306619999995)
Gln Glu Gln Pro
C20H32N6O9 (500.22306619999995)
Gln His Cys Asn
Gln His Asn Cys
Gln Asn Cys His
Gln Asn His Cys
Gln Pro Glu Gln
C20H32N6O9 (500.22306619999995)
Gln Pro Gln Glu
C20H32N6O9 (500.22306619999995)
Gln Gln Glu Pro
C20H32N6O9 (500.22306619999995)
Gln Gln Pro Glu
C20H32N6O9 (500.22306619999995)
Arg Asp Asn Pro
C19H32N8O8 (500.23429919999995)
Arg Asp Pro Asn
C19H32N8O8 (500.23429919999995)
Arg Asn Asp Pro
C19H32N8O8 (500.23429919999995)
Arg Asn Pro Asp
C19H32N8O8 (500.23429919999995)
Arg Pro Asp Asn
C19H32N8O8 (500.23429919999995)
Arg Pro Asn Asp
C19H32N8O8 (500.23429919999995)
Ser Glu Glu His
C19H28N6O10 (500.18668279999997)
Ser Glu His Glu
C19H28N6O10 (500.18668279999997)
Ser Phe Phe Thr
C25H32N4O7 (500.22708819999997)
Ser Phe Thr Phe
C25H32N4O7 (500.22708819999997)
Ser His Glu Glu
C19H28N6O10 (500.18668279999997)
Ser Met Thr Tyr
Ser Met Tyr Thr
Ser Thr Phe Phe
C25H32N4O7 (500.22708819999997)
Ser Thr Met Tyr
Ser Thr Tyr Met
Ser Tyr Met Thr
Ser Tyr Thr Met
Thr Ala Phe Tyr
C25H32N4O7 (500.22708819999997)
Thr Ala Tyr Phe
C25H32N4O7 (500.22708819999997)
Thr Asp Glu His
C19H28N6O10 (500.18668279999997)
Thr Asp His Glu
C19H28N6O10 (500.18668279999997)
Thr Glu Asp His
C19H28N6O10 (500.18668279999997)
Thr Glu His Asp
C19H28N6O10 (500.18668279999997)
Thr Phe Ala Tyr
C25H32N4O7 (500.22708819999997)
Thr Phe Phe Ser
C25H32N4O7 (500.22708819999997)
Thr Phe Ser Phe
C25H32N4O7 (500.22708819999997)
Thr Phe Tyr Ala
C25H32N4O7 (500.22708819999997)
Thr His Asp Glu
C19H28N6O10 (500.18668279999997)
Thr His Glu Asp
C19H28N6O10 (500.18668279999997)
Thr Met Ser Tyr
Thr Met Tyr Ser
Thr Ser Phe Phe
C25H32N4O7 (500.22708819999997)
Thr Ser Met Tyr
Thr Ser Tyr Met
Thr Tyr Ala Phe
C25H32N4O7 (500.22708819999997)
Thr Tyr Phe Ala
C25H32N4O7 (500.22708819999997)
Thr Tyr Met Ser
Thr Tyr Ser Met
Val Asp His Met
Val Asp Met His
Val Gly Tyr Tyr
C25H32N4O7 (500.22708819999997)
Val His Asp Met
Val His Met Asp
Val Met Asp His
Val Met His Asp
Val Tyr Gly Tyr
C25H32N4O7 (500.22708819999997)
Val Tyr Tyr Gly
C25H32N4O7 (500.22708819999997)
Tyr Ala Phe Thr
C25H32N4O7 (500.22708819999997)
Tyr Ala Thr Phe
C25H32N4O7 (500.22708819999997)
Tyr Asp Phe Gly
Tyr Asp Gly Phe
Tyr Phe Ala Thr
C25H32N4O7 (500.22708819999997)
Tyr Phe Asp Gly
Tyr Phe Gly Asp
Tyr Phe Thr Ala
C25H32N4O7 (500.22708819999997)
Tyr Gly Asp Phe
Tyr Gly Phe Asp
Tyr Gly Val Tyr
C25H32N4O7 (500.22708819999997)
Tyr Gly Tyr Val
C25H32N4O7 (500.22708819999997)
Tyr Met Ser Thr
Tyr Met Thr Ser
Tyr Ser Met Thr
Tyr Ser Thr Met
Tyr Thr Ala Phe
C25H32N4O7 (500.22708819999997)
Tyr Thr Phe Ala
C25H32N4O7 (500.22708819999997)
Tyr Thr Met Ser
Tyr Thr Ser Met
Tyr Val Gly Tyr
C25H32N4O7 (500.22708819999997)
Tyr Val Tyr Gly
C25H32N4O7 (500.22708819999997)
Tyr Tyr Gly Val
C25H32N4O7 (500.22708819999997)
Tyr Tyr Val Gly
C25H32N4O7 (500.22708819999997)
Flutide
C25H31F3O5S (500.18441920000004)
punaglandin 6
Isoaustin
punaglandin 6
rolapitant
A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Rolapitant (SCH619734) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant does not interact with CYP3A4. Rolapitant shows potent anti-emetic activity in a ferret emesis model[1][2].
Dovitinib lactate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
β-Alanine, N-[[2-[[[4-(aminocarbonyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
H-D-Phe-Phe-Arg-chloromethylketone trifluoroacetate salt
(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent
Managlinat dialanetil
C21H33N4O6PS (500.18583280000007)
C471 - Enzyme Inhibitor
(1S,3S)-3-ethyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoic acid
2-amino-N-[2-[[1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]amino]-3-phenylpropanoyl]-3-phenylpropanamide
(2S)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H33FN2O4S (500.21449500000006)
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
6,9-difluoro-11-hydroxy-17-(3-hydroxy-2-oxopropyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioic acid S-(fluoromethyl) ester
C25H31F3O5S (500.18441920000004)
(2R)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H33FN2O4S (500.21449500000006)
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide
(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(2S)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H33FN2O4S (500.21449500000006)
(2R)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H33FN2O4S (500.21449500000006)
N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
(1S)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
9-(2-Carboxy-4-isothiocyanatophenyl)-3,6-bis(diethylamino)xanthylium
(2S,3S,4S,5R)-6-[7-carbamoyl-5-hydroxy-1-(4-phenylbutan-2-yl)indol-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
(2S,3S,4S,5R)-6-[7-carbamoyl-6-hydroxy-1-(4-phenylbutan-2-yl)indol-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Fluticasone propionate (Flonase, Veramyst)
C25H31F3O5S (500.18441920000004)
7-amino-4,5,6-triethoxy-3-(9-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-7-yl)-3H-2-benzofuran-1-one
C26H32N2O8 (500.21585519999996)
13-deoxycarminomycin(1+)
An anthracyline cation that is the conjugate acid of 13-deoxycarminomycin, obtained by protonation of the amino group. Major microspecies at pH 7.3
ELN-441958
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].
(1s,2s,3r,7s,8s,9r,13s)-3,8-dimethyl-13-{[(2z)-2-methylbut-2-enoyl]oxy}-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate
3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl 2-methylbut-2-enoate
(12r)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one
12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-6,11',15'-trioxo-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-en-8'-yl acetate
methyl 2-[6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]-2-hydroxyacetate
(8s,9r,10s)-3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2e)-2-methylbut-2-enoate
(6s)-2-[2-(4-hydroxyphenyl)ethyl]-6-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]-5,6-dihydropyran-4-one
27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18r)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
(4r,7r,7ar)-3,7a-dibenzyl-4-hydroxy-4,7-diphenyl-6,7-dihydro-1-benzofuran-2,5-dione
(9r)-8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol
(12'z,18'z,20'z)-6'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
(8r,9r,10r)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl but-2-enoate
2-{3-[(2s)-2,3-dihydroxy-3-methylbutyl]-4-hydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-5,7-dihydroxy-3,6-dimethoxychromen-4-one
11,12,16-trimethyl (1r,12r,13r,16r,23r)-12-hydroxy-6,8-dioxa-11,20-diazahexacyclo[14.6.1.0¹,¹³.0²,¹⁰.0⁵,⁹.0²⁰,²³]tricosa-2(10),3,5(9),17-tetraene-11,12,16-tricarboxylate
3,8-dimethyl-13-[(2-methylbut-2-enoyl)oxy]-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl 2-[(acetyloxy)methyl]but-2-enoate
(1'r,2s,3'r,8'r,12'e,18'e,20'e,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
16,18-dimethyl 18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate
(1'r,2s,3'r,8'r,12'z,18'e,20'z,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
15-(2-hydroxy-2-methylpropyl)-4,13,13,18-tetramethyl-12,26-dioxa-4,18-diazahexacyclo[12.12.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-2(11),5,7,9,16(25),19,21,23-octaene-3,17-dione
12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate
C24H33ClO9 (500.18129980000003)
(1'r,2r,3'r,8'r,13'r,18'e,20'z,24'r,25's)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',12',17',22'-tetrone
methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18s)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
[(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[(2s)-3-(octanoyloxy)-2-(propanoyloxy)propoxy]oxan-2-yl]methanesulfonic acid
C20H36O12S (500.19273760000004)
methyl 3-[7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
methyl 3-[11'-(furan-3-yl)-3'-hydroxy-2',3,3,6',10'-pentamethyl-4',13'-dioxo-12',15'-dioxaspiro[oxirane-2,5'-tetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan]-6'-yl]prop-2-enoate
13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-20-ethoxy-15-hydroxy-11-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
C26H32N2O8 (500.21585519999996)